欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

乳腺癌休眠的分子因素和临床意义

Molecular Determinants and Clinical Implications of Breast Cancer Dormancy

作者:J. Lee S. Lin S. Wang 作者单位:M. D. Anderson Cancer Center, Smithville, TX. 加工时间:2015-03-09 信息来源:科技报告(AD) 索取原文[8 页]
关键词:乳腺癌;癌症休眠;临床医学;一致性;损害;脱氧核糖核的酸;休眠;药物;代谢性应激;代谢;Petaka设备;静止;耐药性;压力(生理)
摘 要:During the first year of this project, we have made significant progress in our proposed work. We developed and tested two cell models to induce cancer dormancy: metabolic stress and Petaka incubation. We found that metabolic stress enriched quiescence population but caused spontaneous DNA breaks. Given that the goal of this project is to determine if and how DNA damage repairs play a critical role in dormancy state, metabolic stress-induced dormancy appears not to be appropriate for our study. In Petaka-induced dormancy, we found that cell dormancy facilitated DNA damage repair when cells were pre-treated with DNA damage agents, and promoted transformation phenotype and drug resistance after exited from dormant state. These observations are consistent with the fact that recurrent breast cancers are usually more malignant and more resistant to original therapy. Finally, we applied microarray analysis in cells before dormancy, maintaining in dormancy, and exited from dormancy. Further analysis of these expression profiles will help us to identify the key molecular determinants that control dormancy at different stages.
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服